August 15, 2022 at 03:43PM Size and shape of human mesenchymal stem cells may predict future biochemical behavior potentially linked to supporting bone growth

Scientists at the US Food and Drug Administration (FDA) are studying characteristic of human mesenchymal stem cells (MSC) that can correlate with mineralization of MSC, which is a prerequisite step in bone formation.

Mineralization is the deposition of calcium by human mesenchymal stem cells (MSCs) that have received the appropriate stimulation. MSCs can turn into a variety of cells types, including those that form fat tissue, cartilage, or bones, depending on the stimulation. Many scientists, including those at FDA, are studying their properties for potential use for a variety of therapies aimed at restoring certain tissues in animals and humans.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/jm4tA3M